CD38 bispecific antibodies can bind to CD38 on tumor cells and cytotoxic immune effector cells (T cells, a small number of NK cells), playing the antitumor role of the antibody itself and activating effector cells to attack tumor cells. The gene discussed is CD38; the disease is neoplasm.